A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities
- PMID: 9607364
- DOI: 10.1016/s0360-3016(98)00057-1
A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities
Abstract
Purpose: This study tests an accepted claim regarding tumor control (TCP) and normal tissue complication (NTCP) probability functions. The claim is that treatment plans can be ranked using relative probabilities, even when the absolute probabilities are unknown. The assumption supports the use of probability models for plan optimization and the comparison of treatment techniques.
Methods: The claim was tested using a hypothetical model consisting of two tissues, and illustrated with clinical data. Plans were scored using the probability of uncomplicated tumor control. The scores of different plans were compared by fixing their relative risks for an individual tissue complication, but adjusting the absolute probability levels up or down. The tested claim is that the plan rankings should not change.
Results: In the two-tissue model, the rankings of competing plans were reversed by doubling all the probabilities. The preference ordering of lung cancer plans changed after the risk of pulmonary complication was reduced by 3-fold. In another site, the ranking of plans by overall complication-free probability was disturbed by errors that preserved the ordering of plans with respect to any individual complication. An adjustment of +/- 2.5% in the initial NTCP values for two tissues changed the direction in which a plan score moved in response to a fixed tradeoff in complication risk in an optimization search.
Conclusions: Contrary to claims, plan rankings are not determined by the relative probabilities of adverse events. The effect on plan scores of trading one complication for another depends on the absolute levels of risk. Absolute errors in NTCP and TCP functions result in the wrong ranking of plans, even when relative probabilities are correct. An optimization routine based on TCP and NTCP calculations may be forced in the wrong direction by small errors in the probability estimates.
Comment in
-
A more robust biologically based ranking criterion for treatment plans.Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):697-8. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078658 No abstract available.
Similar articles
-
Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).Br J Radiol. 2015 Jun;88(1050):20140839. doi: 10.1259/bjr.20140839. Epub 2015 Apr 17. Br J Radiol. 2015. PMID: 25882689 Free PMC article.
-
Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):639-48. doi: 10.1016/s0360-3016(00)00419-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 10837946
-
"SABER": A new software tool for radiotherapy treatment plan evaluation.Med Phys. 2010 Nov;37(11):5586-92. doi: 10.1118/1.3497152. Med Phys. 2010. PMID: 21158270
-
[Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: methodologic, physical, and biological aspects].Cancer Radiother. 2002 Nov;6 Suppl 1:155s-165s. doi: 10.1016/s1278-3218(02)00221-4. Cancer Radiother. 2002. PMID: 12587394 Review. French.
-
Normal tissue complication probability (NTCP) models for modern radiation therapy.Semin Oncol. 2019 Jun;46(3):210-218. doi: 10.1053/j.seminoncol.2019.07.006. Epub 2019 Aug 13. Semin Oncol. 2019. PMID: 31506196 Review.
Cited by
-
A new plan quality index for dose painting radiotherapy.J Appl Clin Med Phys. 2014 Jul 8;15(4):4941. doi: 10.1120/jacmp.v15i4.4941. J Appl Clin Med Phys. 2014. PMID: 25207424 Free PMC article.
-
Dynamic Neutrophil-to-Lymphocyte Ratio at 3-4 weeks of Intensity-Modulated Radiotherapy Combined with Normal Liver Volume Predicts Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma: A Retrospective Study.J Inflamm Res. 2025 Jun 17;18:7879-7892. doi: 10.2147/JIR.S523065. eCollection 2025. J Inflamm Res. 2025. PMID: 40546400 Free PMC article.
-
A dose-volume-based tool for evaluating and ranking IMRT treatment plans.J Appl Clin Med Phys. 2004 Autumn;5(4):1-14. doi: 10.1120/jacmp.v5i4.1981. Epub 2004 Oct 1. J Appl Clin Med Phys. 2004. PMID: 15738916 Free PMC article.
-
Dose volume histogram analysis and comparison of different radiobiological models using in-house developed software.J Med Phys. 2011 Oct;36(4):220-9. doi: 10.4103/0971-6203.89971. J Med Phys. 2011. PMID: 22228931 Free PMC article.
-
A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife.PLoS One. 2018 Nov 27;13(11):e0208086. doi: 10.1371/journal.pone.0208086. eCollection 2018. PLoS One. 2018. PMID: 30481228 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical